The DOI matches its Crossref record; 57 of the 57 references it cites were found in a registry or an index.
The Global Burden of Liver Disease
Open accessAbstract
Chronic liver disease (CLD) and its associated complications (cirrhosis and liver cancer) cause significant mortality, morbidity, and economic burden. Published data from the World Health Organization and/or the Global Burden of Disease show that the burden of CLD is large and increasing, primarily owing to the increasing burden of nonalcoholic fatty liver disease and alcohol-related liver disease (ALD). Middle Eastern, Northern African, and Asian regions of the globe are most affected by hepatitis B and hepatitis C virus. Furthermore, Middle Eastern and North African regions also are affected by nonalcoholic fatty liver disease, and Eastern European, West African, and Central Asian regions are affected by ALD. In this context, the rate of increase for cirrhosis is highest in the Middle East, as well as in middle high and high sociodemographic index (SDI) regions. On the other hand, the highest SDI countries are experiencing increasing rates of hepatocellular carcinoma (HCC). Assessing HCC burden based on country and etiology shows that China, Korea, India, Japan, and Thailand have the highest hepatitis B virus-related HCC cases, while China, Japan, and the United States have the highest hepatitis C virus-related HCC cases. Additionally, the United States has the highest ALD-related HCC cases, while India, the United States, and Thailand have the highest nonalcoholic steatohepatitis-related HCC cases. Although the burden of CLD is increasing globally, regions of the world are impacted differently as a result of a number of sociodemographic factors.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Murray, C. J. L., Aravkin, A. Y., Zheng, P., Abbafati, C., Abbas, K. M., Abbasi-Kangevari, M., Abd-Allah, F., Abdelalim, A., Abdollahi, M., Abdollahpour, I., et al. (2020) · The Lancet · doi:10.1016/s0140-6736(20)30752-2 · Cited by 9,854
Krupp, L. B. (1989) · Archives of Neurology · doi:10.1001/archneur.1989.00520460115022 · Cited by 6,172
Burden of liver diseases in the world
Asrani, S. K., Devarbhavi, H., Eaton, J., & Kamath, P. S. (2019) · Journal of Hepatology · doi:10.1016/j.jhep.2018.09.014 · Cited by 3,783
Younossi, Z. M., Golabi, P., Paik, J. M., Henry, A., Van Dongen, C., & Henry, L. (2023) · Hepatology · doi:10.1097/hep.0000000000000004 · Cited by 3,383
Self-citationThe Validity and Reproducibility of a Work Productivity and Activity Impairment Instrument
Reilly, M. C., Zbrozek, A. S., & Dukes, E. M. (1993) · PharmacoEconomics · doi:10.2165/00019053-199304050-00006 · Cited by 3,071
Estes, C., Razavi, H., Loomba, R., Younossi, Z., & Sanyal, A. J. (2018) · Hepatology · doi:10.1002/hep.29466 · Cited by 2,399
Self-citationGlobal Burden of Disease 2019 Cancer Collaboration, Kocarnik, J. M., Compton, K., Dean, F. E., Fu, W., Gaw, B. L., Harvey, J. D., Henrikson, H. J., Lu, D., Pennini, A., et al. (2022) · JAMA Oncology · doi:10.1001/jamaoncol.2021.6987 · Cited by 2,026
Estes, C., Anstee, Q. M., Arias-Loste, M. T., Bantel, H., Bellentani, S., Caballeria, J., Colombo, M., Craxi, A., Crespo, J., Day, C. P., et al. (2018) · Journal of Hepatology · doi:10.1016/j.jhep.2018.05.036 · Cited by 1,980
Self-citationSepanlou, S. G., Safiri, S., Bisignano, C., Ikuta, K. S., Merat, S., Saberifiroozi, M., Poustchi, H., Tsoi, D., Colombara, D. V., Abdoli, A., et al. (2020) · The Lancet Gastroenterology & Hepatology · doi:10.1016/s2468-1253(19)30349-8 · Cited by 1,714
Razavi-Shearer, D., Gamkrelidze, I., Nguyen, M. H., Chen, D.-S., Van Damme, P., Abbas, Z., Abdulla, M., Abou Rached, A., Adda, D., Aho, I., et al. (2018) · The Lancet Gastroenterology & Hepatology · doi:10.1016/s2468-1253(18)30056-6 · Cited by 1,661
Global distribution and prevalence of hepatitis C virus genotypes
Messina, J. P., Humphreys, I., Flaxman, A., Brown, A., Cooke, G. S., Pybus, O. G., & Barnes, E. (2015) · Hepatology · doi:10.1002/hep.27259 · Cited by 1,589
The relationship between different dimensions of alcohol use and the burden of disease—an update
Rehm, J., Gmel, G. E., Gmel, G., Hasan, O. S. M., Imtiaz, S., Popova, S., Probst, C., Roerecke, M., Room, R., Samokhvalov, A. V., et al. (2017) · Addiction · doi:10.1111/add.13757 · Cited by 1,204
Contemporary Epidemiology of Chronic Liver Disease and Cirrhosis
Moon, A. M., Singal, A. G., & Tapper, E. B. (2020) · Clinical Gastroenterology and Hepatology · doi:10.1016/j.cgh.2019.07.060 · Cited by 1,150
Dai, H., Alsalhe, T. A., Chalghaf, N., Riccò, M., Bragazzi, N. L., & Wu, J. (2020) · PLOS Medicine · doi:10.1371/journal.pmed.1003198 · Cited by 865
Sheena, B. S., Hiebert, L., Han, H., Ippolito, H., Abbasi-Kangevari, M., Abbasi-Kangevari, Z., Abbastabar, H., Abdoli, A., Abubaker Ali, H., Adane, M. M., et al. (2022) · The Lancet Gastroenterology & Hepatology · doi:10.1016/s2468-1253(22)00124-8 · Cited by 805
Paik, J. M., Golabi, P., Younossi, Y., Mishra, A., & Younossi, Z. M. (2020) · Hepatology · doi:10.1002/hep.31173 · Cited by 788
Self-citationYounossi, Z. M., Guyatt, G., Kiwi, M., Boparai, N., & King, D. (1999) · Gut · doi:10.1136/gut.45.2.295 · Cited by 670
Self-citationBlach, S., Terrault, N. A., Tacke, F., Gamkrelidze, I., Craxi, A., Tanaka, J., Waked, I., Dore, G. J., Abbas, Z., Abdallah, A. R., et al. (2022) · The Lancet Gastroenterology & Hepatology · doi:10.1016/s2468-1253(21)00472-6 · Cited by 641
Interpreting SF&-36 summary health measures: A response
Ware, J. E., & Kosinski, M. (2001) · Quality of Life Research · doi:10.1023/a:1012588218728 · Cited by 566
Spearman, C. W., Dusheiko, G. M., Hellard, M., & Sonderup, M. (2019) · The Lancet · doi:10.1016/s0140-6736(19)32320-7 · Cited by 404
Global reporting of progress towards elimination of hepatitis B and hepatitis C
Cui, F., Blach, S., Manzengo Mingiedi, C., Gonzalez, M. A., Sabry Alaama, A., Mozalevskis, A., Séguy, N., Rewari, B. B., Chan, P.-L., Le, L.-V., et al. (2023) · The Lancet Gastroenterology & Hepatology · doi:10.1016/s2468-1253(22)00386-7 · Cited by 327
Global burden of NAFLD and chronic liver disease among adolescents and young adults
Paik, J. M., Kabbara, K., Eberly, K. E., Younossi, Y., Henry, L., & Younossi, Z. M. (2022) · Hepatology · doi:10.1002/hep.32228 · Cited by 249
Self-citationGlobal Burden of Alcohol Use Disorders and Alcohol Liver Disease
Rehm, J., & Shield, K. D. (2019) · Biomedicines · doi:10.3390/biomedicines7040099 · Cited by 222
Direct and Indirect Economic Burden of Chronic Liver Disease in the United States
Stepanova, M., De Avila, L., Afendy, M., Younossi, I., Pham, H., Cable, R., & Younossi, Z. M. (2017) · Clinical Gastroenterology and Hepatology · doi:10.1016/j.cgh.2016.07.020 · Cited by 179
Self-citationA narrative review of alcohol consumption as a risk factor for global burden of disease
Rehm, J., & Imtiaz, S. (2016) · Substance Abuse Treatment, Prevention, and Policy · doi:10.1186/s13011-016-0081-2 · Cited by 177
Modelling NAFLD disease burden in four Asian regions—2019‐2030
Estes, C., Chan, H. L. Y., Chien, R. N., Chuang, W., Fung, J., Goh, G. B.-B., Hu, T. H., Huang, J., Jang, B. K., Jun, D. W., et al. (2020) · Alimentary Pharmacology & Therapeutics · doi:10.1111/apt.15673 · Cited by 175
Self-citationPredictors of health‐related quality of life in patients with chronic liver disease
AFENDY, A., KALLMAN, J. B., STEPANOVA, M., YOUNOSZAI, Z., AQUINO, R. D., BIANCHI, G., MARCHESINI, G., & YOUNOSSI, Z. M. (2009) · Alimentary Pharmacology & Therapeutics · doi:10.1111/j.1365-2036.2009.04061.x · Cited by 161
Self-citationAsian perspective on NAFLD-associated HCC
Yip, T. C.-F., Lee, H. W., Chan, W. K., Wong, G. L.-H., & Wong, V. W.-S. (2022) · Journal of Hepatology · doi:10.1016/j.jhep.2021.09.024 · Cited by 161
Self-citationCost of non-alcoholic steatohepatitis in Europe and the USA: The GAIN study
O’Hara, J., Finnegan, A. P., Dhillon, H. S., Ruiz‐Casas, L., Pedra, G., Franks, B., Morgan, G., Hebditch, V., Jönsson, B., Mabhala, M. A., et al. (2020) · JHEP Reports · doi:10.1016/j.jhepr.2020.100142 · Cited by 142
Self-citationLiu, Y., Zheng, J., Hao, J., Wang, R. R., Liu, X., Gu, P., Yu, H., Yu, Y., Wu, C.-X., Ou, B., et al. (2022) · Cancer Medicine · doi:10.1002/cam4.4551 · Cited by 136
Poor Awareness of Liver Disease Among Adults With NAFLD in the United States
Alqahtani, S. A., Paik, J. M., Biswas, R., Arshad, T., Henry, L. L., & Younossi, Z. M. (2021) · Hepatology Communications · doi:10.1002/hep4.1765 · Cited by 131
Self-citationYounossi, Z. M., Stepanova, M., Henry, L. L., Racila, A., Lam, B. P., Phạm, T. T. H., & Hunt, S. (2017) · Liver International · doi:10.1111/liv.13391 · Cited by 113
Self-citationYounossi, Z. M., Yilmaz, Y. N., Yu, M., Wong, V. W., Castellanos, M., Va, I., Duseja, A. K., Méndez‐Sánchez, N., Eguchi, Y., Bugianesi, E., et al. (2021) · Clinical Gastroenterology and Hepatology · doi:10.1016/j.cgh.2021.11.004 · Cited by 113
Self-citationHuber, Y., Boyle, M., Hallsworth, K., TINIAKOS, D. G., Straub, B. K., Labenz, C., Ruckes, C., Galle, P. R., Romero‐Gómez, M., Anstee, Q. M., et al. (2018) · Clinical Gastroenterology and Hepatology · doi:10.1016/j.cgh.2018.12.016 · Cited by 110
Self-citationYounossi, Z. M., Aggarwal, P., Shrestha, I., Fernandes, J. D. D. R., Johansen, P., Augusto, M., & Nair, S. (2022) · JHEP Reports · doi:10.1016/j.jhepr.2022.100525 · Cited by 109
Self-citationTordrup, D., Hutin, Y. J., Stenberg, K., Lauer, J. A., Hutton, D. W., Toy, M., Scott, N., Bulterys, M., Ball, A. L., & Hirnschall, G. O. (2019) · The Lancet Global Health · doi:10.1016/s2214-109x(19)30272-4 · Cited by 108
Zoratti, M. J., Siddiqua, A., Morassut, R. E., Zeraatkar, D., Chou, R., van Holten, J., Xie, F., & Druyts, E. (2020) · EClinicalMedicine · doi:10.1016/j.eclinm.2019.12.007 · Cited by 105
Financial burden in adults with chronic liver disease: A scoping review
Ufere, N. N., Satapathy, N., Philpotts, L. L., Lai, J. C., & Serper, M. (2022) · Liver Transplantation · doi:10.1002/lt.26514 · Cited by 80
Schwarzinger, M., Baillot, S., Yazdanpanah, Y., Rehm, J. T., & Mallet, V. O. (2017) · Journal of Hepatology · doi:10.1016/j.jhep.2017.03.031 · Cited by 67
The Economic Burden of Non-Alcoholic Steatohepatitis: A Systematic Review
Witkowski, M., Moreno, S. I., Fernandes, J. D. R., Johansen, P., Augusto, M., & Nair, S. (2022) · PharmacoEconomics · doi:10.1007/s40273-022-01140-y · Cited by 62
Younossi, Z. M., Wong, V. W., Anstee, Q. M., Romero‐Gómez, M., Trauner, M., Harrison, S. A., Lawitz, E., Okanoue, T., Camargo, M., Kersey, K., et al. (2020) · Hepatology Communications · doi:10.1002/hep4.1581 · Cited by 57
Self-citationCao, G., Jing, W., Liu, J., & Liu, M. (2022) · Hepatology International · doi:10.1007/s12072-022-10410-y · Cited by 53
Younossi, Z. M., Stepanova, M., & Henry, L. L. (2016) · Value in Health · doi:10.1016/j.jval.2016.02.005 · Cited by 52
Self-citationYounossi, Z. M., Stepanova, M., Younossi, I. M., & Racila, A. (2019) · Clinical Gastroenterology and Hepatology · doi:10.1016/j.cgh.2019.01.001 · Cited by 52
Self-citationYousafzai, M. T., Bajis, S., Alavi, M., Grebely, J., Dore, G. J., & Hajarizadeh, B. (2021) · Journal of Viral Hepatitis · doi:10.1111/jvh.13574 · Cited by 51
Pecoraro, V., Banzi, R., Cariani, E., Chester, J., Villa, E., D’Amico, R., Bertelè, V., & Trenti, T. (2018) · Journal of Clinical and Experimental Hepatology · doi:10.1016/j.jceh.2018.07.004 · Cited by 50
Knowledge about infection is the only predictor of treatment in patients with chronic hepatitis C
Younossi, Z. M., Stepanova, M., Afendy, M., Lam, B. P., & Mishra, A. (2013) · Journal of Viral Hepatitis · doi:10.1111/jvh.12080 · Cited by 42
Self-citationYounossi, Z. M., Blissett, D., Blissett, R. S., Henry, L. L., Younossi, Y., Beckerman, R., & Hunt, S. (2017) · Liver International · doi:10.1111/liv.13519 · Cited by 41
Self-citationYounossi, Z. M., Stepanova, M., Noureddin, M., Kowdley, K. V., Strasser, S. I., Kohli, A., Ruane, P. J., Shiffman, M. L., Sheikh, A. M., Gunn, N., et al. (2021) · Hepatology Communications · doi:10.1002/hep4.1710 · Cited by 37
Self-citationHealth-related quality of life in Cuban patients with chronic liver disease: A real-world experience
Castellanos, M., Borges-González, S. A., Stepanova, M., Velázquez, M. I., Ruenes-Domech, C., Suero, S. M. G., Guridi, Z. D., Arús, E., Racila, A., & Younossi, Z. M. (2020) · Annals of Hepatology · doi:10.1016/j.aohep.2020.10.005 · Cited by 36
Self-citationGhamari, S., Yoosefi, M., Abbasi-Kangevari, M., Malekpour, M., Moghaddam, S. S., Shahin, S., Esfahani, Z., Koolaji, S., Shobeiri, P., Ghaffari, A., et al. (2022) · Hepatology Communications · doi:10.1002/hep4.1910 · Cited by 30
Younossi, Z. M., Stepanova, M., Younossi, I. M., & Racila, A. (2020) · Journal of Viral Hepatitis · doi:10.1111/jvh.13451 · Cited by 29
Self-citationCacoub, P., Bourlière, M., Asselah, T., de Lédinghen, V., Mathurin, P., Hézode, C., Henry, L. L., Stepanova, M., & Younossi, Z. M. (2018) · Value in Health · doi:10.1016/j.jval.2018.01.006 · Cited by 26
Self-citationValery, P., Bernardes, C., Hayward, K., Hartel, G., Haynes, K., Gordon, L., Stuart, K., Wright, P. L., Johnson, A. L., & Powell, E. (2022) · BMC Gastroenterology · doi:10.1186/s12876-022-02407-6 · Cited by 25
Younossi, Z. M., Stepanova, M., Henry, L. L., Han, K., Ahn, S. H., Lim, Y., Chuang, W., Kao, J., Kính, N. V., Lai, C., et al. (2017) · Liver International · doi:10.1111/liv.13650 · Cited by 22
Self-citationYounossi, Z. M., Tanaka, A., Eguchi, Y., Henry, L. L., Beckerman, R., & Mizokami, M. (2018) · Journal of Viral Hepatitis · doi:10.1111/jvh.12886 · Cited by 22
Self-citationStepanova, M., Younossi, I. M., Racila, A., & Younossi, Z. M. (2017) · Value in Health · doi:10.1016/j.jval.2017.10.005 · Cited by 10
Self-citation
Cited by
Metabolic reprogramming in liver fibrosis
Horn, P., & Tacke, F. (2024) · Cell Metabolism · doi:10.1016/j.cmet.2024.05.003 · Cited by 432
Stefan, N., Yki-Järvinen, H., & Neuschwander-Tetri, B. A. (2025) · The Lancet Diabetes & Endocrinology · doi:10.1016/s2213-8587(24)00318-8 · Cited by 392
Wu, Z., Xia, F., & Lin, R. (2024) · Journal of Hematology & Oncology · doi:10.1186/s13045-024-01640-8 · Cited by 365
Liver diseases: epidemiology, causes, trends and predictions
Gan, C., Yuan, Y., Shen, H., Gao, J., Kong, X., Che, Z., Guo, Y., Wang, H., Dong, E., & Xiao, J. (2025) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-024-02072-z · Cited by 310
Younossi, Z. M., Zelber-Sagi, S., Lazarus, J. V., Wong, V. W.-S., Yilmaz, Y., Duseja, A., Eguchi, Y., Castera, L., Pessoa, M. G., Oliveira, C. P., et al. (2025) · Gastroenterology · doi:10.1053/j.gastro.2025.02.044 · Cited by 194
Self-citation
Metadata
- Authors
- Younossi, Z. M., Wong, G., Anstee, Q. M., & Henry, L.
- Venue
- Clinical Gastroenterology and Hepatology
- Publisher
- Elsevier BV
- Published
- 2023-07
- Volume
- 21
- Issue
- 8
- Pages
- 1978-1991
- ISSN
- 1542-3565 (ISSN-L)
- OpenAlex
- W4367316580
- Cited by
- 500
- References
- 57
- FWCI
- 83.29
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.